Sign up to save your podcasts
Or
Share #006 - Danny Motyka, CEO of Psygen
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
#006 - Danny Motyka, CEO of Psygen
Episode 6 - June 17th 2020
Danny Motyka - CEO of https://www.psygen.ca/ (Psygen)
Presented by https://thethirdwave.co/ (Paul Austin) of https://thethirdwave.co/ (Third Wave)
Psygen
Psygen is a manufacturer of pharmaceutical-grade psychedelic drug products for clinical research and therapeutic applications. Danny Motyka has long been a proponent of psychedelic medicine. Personal experience with psilocybin and LSD helped him understand and manage major depression, and ultimately inspired him to dedicate his attention to psychedelic medicinal chemistry. After graduating from the University of Victoria with an honours degree in chemistry, he began his rise through management at Aurora Cannabis. His career with Aurora included multiple years as General Manager of a cannabis cultivation and processing facility, providing foundational experience with the intricacies of good manufacturing practices, and a strong knowledge of the Controlled Drugs and Substances Act and the associated regulations.
PSYCHEDELIC INSIDERS
Each week, we'll be diving deep with psychedelic industry leaders into the startup scene, IPO tracks, the investment landscape, financing rounds, and the operational side of running a high-performance psychedelic company.
View all episodes
By Microdose Psychedelic InsightsEpisode 6 - June 17th 2020
Danny Motyka - CEO of https://www.psygen.ca/ (Psygen)
Presented by https://thethirdwave.co/ (Paul Austin) of https://thethirdwave.co/ (Third Wave)
Psygen
Psygen is a manufacturer of pharmaceutical-grade psychedelic drug products for clinical research and therapeutic applications. Danny Motyka has long been a proponent of psychedelic medicine. Personal experience with psilocybin and LSD helped him understand and manage major depression, and ultimately inspired him to dedicate his attention to psychedelic medicinal chemistry. After graduating from the University of Victoria with an honours degree in chemistry, he began his rise through management at Aurora Cannabis. His career with Aurora included multiple years as General Manager of a cannabis cultivation and processing facility, providing foundational experience with the intricacies of good manufacturing practices, and a strong knowledge of the Controlled Drugs and Substances Act and the associated regulations.
PSYCHEDELIC INSIDERS
Each week, we'll be diving deep with psychedelic industry leaders into the startup scene, IPO tracks, the investment landscape, financing rounds, and the operational side of running a high-performance psychedelic company.